Vygon monitors provide improvement for ovarian cancer patients by John Pinching | Mar 13, 2023 | News | 0 Norfolk and Norwich University Hospitals have been using two Mostcare Up devices since 2019 Read More
Norfolk and Norwich University Hospitals establishes therapy for ovarian cancer patients by John Pinching | Nov 15, 2022 | News | 0 Procedure is carried out following the completion of surgery to remove all visible disease Read More
Lynparza hits target in late stage ovarian cancer trial by Anna Smith | Aug 14, 2019 | News | 0 he companies announced earlier this month that the drug was also successful in prostate cancer. Read More
Lynparza ASCO success continues with positive ovarian cancer results by Anna Smith | Jun 5, 2019 | News | 0 The treatment achieved a 72% objective response rate in patients with previously treated germline BRCA1/2-mutated advanced ovarian cancer. Read More